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Abstract
Background: Patients with uncharacteristic inflammatory symptoms such as long-standing fatigue or pain, or a 
prolonged fever, constitute a diagnostic and therapeutic challenge. The aim of the present study was to determine if 
an extended immunophenotyping of lymphocytes and monocytes including activation markers can define disease-
specific patterns, and thus provide valuable diagnostic information for these patients.
Methods: Whole blood from patients with gram-negative bacteraemia, neuroborreliosis, tuberculosis, acute 
mononucleosis, influenza or a mixed connective tissue disorders, as diagnosed by routine culture and serology 
techniques was analysed for lymphocyte and monocyte cell surface markers using a no-wash, no-lyse protocol for 
multi-colour flow cytometry method. The immunophenotyping included the activation markers HLA-DR and CD40. 
Plasma levels of soluble TNF alpha receptors were analysed by ELISA.
Results: An informative pattern was obtained by combining two of the analysed parameters: (i), the fractions of HLA-
DR-expressing CD4+ T cells and CD8+ T cells, respectively, and (ii), the level of CD40 on CD14+ CD16- monocytes. 
Patients infected with gram-negative bacteria or EBV showed a marked increase in monocyte CD40, while this effect 
was less pronounced for tuberculosis, borrelia and influenza. The bacterial agents could be distinguished from the viral 
agents by the T cell result; CD4+ T cells reacting in bacterial infection, and the CD8+ T cells dominating for the viruses. 
Patients with mixed connective tissue disorders also showed increased activation, but with similar engagement of 
CD4+ and CD8+ T cells. Analysis of soluble TNF alpha receptors was less informative due to a large inter-individual 
variation.
Conclusion: Immunophenotyping including the combination of the fractions of HLA-DR expressing T cell 
subpopulations with the level of CD40 on monocytes produces an informative pattern, differentiating between 
infections of bacterial and viral origin. Furthermore, a quantitative analysis of these parameters revealed the novel 
finding of characteristic patterns indicating a subacute bacterial infection, such as borreliosis or tuberculosis, or a mixed 
connective tissue disorder. The employed flow cytometric method is suitable for clinical diagnostic laboratories, and 
may help in the assessment of patients with uncharacteristic inflammatory symptoms.
Background
A considerable number of patients display uncharacteris-
tic inflammatory symptoms, and constitute a diagnostic
and therapeutic challenge. The clinical history may be
dominated by long-standing fatigue or pain, or by a pro-
longed fever. A number of reports on patients with incon-
clusive presentation and microbiological test results have
shown that many of them will eventually be assigned with
a diagnosis of tuberculosis or cytomegalovirus infection
[1-4]. These uncharacteristic cases may therefore repre-
sent an early stage, or show an atypical presentation, of a
mixed connective tissue disorder or an infection.
Blood lymphocyte immunophenotyping by flow
cytometry is a routine diagnostic procedure for assess-
ment of lymphoproliferative diseases and HIV patient
immunodeficiency. More recently it has become part also
of the monitoring of patients taking immune-modifying
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drugs such as the rituximab (Mabthera) anti-CD20
monoclonal antibody. The aim of the present study is to
determine if an extended immunophenotyping of lym-
phocytes and monocytes, including cellular activation
markers, can define disease-specific patterns, and thus
provide valuable diagnostic information for patients with
uncharacteristic inflammatory symptoms.
The immune response during experimental infection
with a number of microbial agents has been investigated
in great detail. For some prototype bacterial and viral
i n f e c t i o n s  d a t a  h a s  a l s o  b e e n  c o l l e c t e d  f r o m  p a t i e n t s .
Gram-negative enterobacteriacae strongly stimulate neu-
trophil phagocytosis and cytokine production by mono-
cytes, in addition to effects on B and CD4+ T
lymphocytes [5]. Another strong immunostimulator is
E p s t e i n - B a r r  v i r u s  ( E B V ) ,  w i t h  a s  m u c h  a s  5 0 %  o f  a l l
peripheral blood T cells being specific for this virus dur-
ing the acute phase of the infection [6]. The response to
EBV has been reported to be much dominated by an
increase in number and activation of CD8+ T lympho-
cytes [7,8]. However, for many clinically significant
microbial agents there is information only on a limited
number of cellular immune parameters. For example, the
relative frequencies of CD4+ T helper cells and CD8+ T
cytotoxic cells is known to become altered by many
microbes, for example CD4+ T lymphocytopenia has
been documented in some cases of tuberculosis [9].
Methods
Patients
The samples from patients with an infectious disease
diagnosis were obtained at their first consultation. Their
history was then less than two weeks for the cases with
gram-negative septicemia/pyelonephritis (Gr-) (n = 10, 7
females, 3 males), EBV (n = 4, all females) or influenza
(Inf) (n = 5, all males), but longer for some of the patients
with tuberculosis (Tb) (n = 8, 4 females, 4 males) or neu-
roborreliosis (Bo) (n = 7, 4 females, 3 males). The disease
duration of the mixed connective tissue disorder (MCT)
(n = 5, 4 females, 1 male) cases was not determined. The
final diagnosis was based on a combination of clinical
symptoms and conventional testing using Swedish
national QC approved culture, PCR and serology.
Study design
Ethical permit was obtained from the local ethical com-
mittee at Lund University (Dnr 288/2007) and an
informed consent was given by the participating patients.
Blood analysis
Leukocyte concentration was determined using an
LH750 machine (BeckmanCoulter, Hialeah, FL, USA),
and plasma levels of C-reactive protein (CRP) with an
automated immunoturbidimetric assay system
(IMMAGE immunochemistry system, Beckman Coulter,
Bromma, Sweden) with a minimum detectable dose of 0.2
mg/L, both using Swedish national QC approved clinical
diagnostic methodology. Soluble TNF alpha receptors
(sTNFR) were assessed by a quantitative ELISA according
to the instructions provided by the manufacturer (R&D
Systems, Minneapolis, MN USA). The mean minimum
detectable dose were for sTNFRI 0.77 pg/ml and for
sTNFRII 0.6 pg/ml, with an inter-assay variation of < 10%.
Flow cytometry
Whole blood (50 μl) was incubated at room temperature
with antibodies conjugated with the fluorochromes fluo-
rescein isothiocyanate (FITC), phycoerythrin (PE), PE-
Texas Red and PE-cyanine5 (PE-Cy5) to permit 4-colour
analysis. The following four antibodies were added to
each cell tube: CD8-FITC/CD4-PE/CD3-PE-Texas Red/
HLA-DR-PE-Cy5, CD20-FITC/CD27-PE/CD19-PE-
Texas Red/CD5-PE-Cy5, CD14-FITC/CD40-PE/CD3-
PE-Texas Red/CD16-PE-Cy5, CD8-FITC/CD27-PE/
CD45R0-PE-Texas Red/HLA-DR-PE-Cy5, CD2-FITC/
CD14-FITC/CD15-FITC/CD20-FITC/CD11c-PE/CD45-
PE-Texas Red/HLA-DR-PE-Cy5 (this tube was for deter-
mination of CD11c- HLA-DR+ plasmacytoid dendritic
cells, and contained multiple FITC-labelled monoclonals
in order to define lineage-negative cells), CD19-FITC/
CD34-PE/CD45-PE-Texas Red/HLA-DR-PE-Cy5,
respectively. Background autoflourescence was moni-
tored with 4-colour isotypic non-specific mouse Ig, sepa-
rately for lymphocytes and monocytes, and this PE-
labelled mouse Ig was used also for setting the cut-off for
HLA-DR-positive reaction. Antibody conjugates were
from BeckmanCoulter and DAKO-Cytomation
(Glostrup, Denmark). A no-wash no-lyse protocol was
used. In-house solutions for lysis and fixation were used.
At least 1,000 events were analysed in a FC500 Beckman-
Coulter flow cytometer. Acquisition and analysis was
made using the CXP software (BeckmanCoulter).
Statistical analysis
The non-parametric Wilcoxon's two-sample rank test
(the Mann-Whitney test) was used [10].
A p-value of < 0.05 was regarded as significant.
Results
Several lymphocyte and monocyte subtypes were analy-
sed with regard to their relative frequencies among
peripheral blood leucocytes, and also for activation sta-
tus, in order to evaluate if any of these data can be of clin-
ical value. Patients with active and systemic EBV
infection showed a clearly reduced CD4/CD8 ratio (0.3)
as compared with the normal control group (N) (2.3)
(Figure 1A). This effect was secondary to a strong
increase in the number of CD8+ T cells, as indicated byJanols et al. BMC Infectious Diseases 2010, 10:205
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the increased total blood lymphocyte count of 6.9 × 10 9 /
ml (T able 1) (results from analysis of CD4+ T cell and
CD8+ T cell percentages are not shown). The CD4/CD8
ratio of patients with the other infection types, including
hospitalized cases of influenza, did not significantly differ
from the controls (Figure 1A). The group of mixed con-
nective tissue disorder patients (listed in figures as MCT)
showed a low mean CD4/CD8 ratio (0.9).
T cell activation, as determined by the presence of sur-
face expression of HLA class II (known from in vitro to
become detectable at 2-3 days after stimulation), was
found to be strongly enhanced in the EBV patients, and
Table 1: Leucocyte counts and plasma levels of C-reactive protein (CRP) and soluble TNF alpha receptors
Patient group Neutrophils Monocytes Lymphocytes CRP sTNFRI sTNFRII
Gr-
(6.0-32.3)
17.2
(0.6-1.3)
0.8
(0.6-1.7)
1.1
(114-332)
248**
(5.5-10.3)
8.2**
(6.9-21.3)
14.2**
EBV
(1.4-6.0)
4.6
(0.2-0.6)
0.4
(3.2-18.5)
6.9
(2-57)
30*
(0.4-1.8)
1.1
(8.4-13.0)
10.7
Inf
(2.6-9.1)
6.0
(0.1-0.9)
0.5
(0.3-1.7)
0.9
(55-215)
103**
(1.0-2.0)
1.5
(3.3-5.4)
4.4
Tb
(3.4-9.1)
5.8
(0.4-2.5)
1.1
(0.9-4.3)
2.1
(<2-150)
64*
(0.8-11.3)
3.6*
(2.3-20.8)
7.7
Bo
(1.3-12.8)
7.4
(0.4-0.8)
0.6
(1.0-2.1)
1.6
(<2-11)
6
(0.8-2.3)
1.3*
(2.6-3.4)
3.0
MCT
(1.6-2.6)
2.1
(0.1-0.6)
0.4
(0.1-1.4)
0.8
(2-74)
38* 0.6 3.1
N
(0.08-1.3)
1.7-8.0
(1.7-3.6)
0.1-1.0 1.1-4.8 <2 0.4 2.5
Leucocyte count (cells × 109/L), CRP (mg/L), TNF alpha receptors (pg/ml). For the MCT patient group TNF alpha receptors were determined 
for only one individual. Mean value and range are shown. For the N group (normal controls) leucocyte counts and CRP were not determined, 
and the displayed values represent the reference value ranges provided by the clinical laboratory performing the analysis of the patient 
groups. *P < 0.02, **P < 0.01.
Figure 1 T lymphocytes: (A), ratio of CD4+/CD8+ T cells; (B), activation within the CD4+ and CD8+ T cell subsets. The result for T cell activation 
shows the percentage of HLA class II-expressing cells among all CD4+ T cells and CD8+ T cells, respectively. The indicated activation values are nor-
malized with the result of the normal control individuals being expressed as 1.0, and the dashed lines indicate the level of the normal controls. Patient 
group codes: Gr-, septicaemia and/or pyelonephritis with gram-negative enterobacteria; EBV, Epstein-Barr virus; Inf, influenza; Tb, tuberculosis; Bo, 
neuroborreliosis; MCT, mixed connective tissue disorders; N, normal healthy controls. *p < 0.02 or 0.05, ** p < 0.01.
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notably not only in the CD8+ T cells but also markedly,
although to a lesser degree, in the CD4+ T helper cells
(Figure 1B). In the Gr- patient group (gram-negative
bacteraemia or pyelonephritis) both of the T cell subtypes
showed a low activation. In the second group of virus
infection, influenza (Inf), activation was increased in the
CD8+ T cells, and to some low extent also in the CD4+ T.
However, for the Gr- and influenza groups, the differ-
ences as compared with the normal controls did not
reach statistical significance. Conversely, both of the less
acute bacterial infection patient groups showed normal
CD8+ T activation, but an increased level in the CD4+ T
cells, with significance for the Tb (tuberculosis) group at
p < 0.02. There was no statistical significance for any of
the differences observed between the Tb, Bo and MCT
groups. Flow cytometry dot-plot raw data from represen-
tative cases are presented in Figure 2A-F, illustrating the
strategy for determination of positivity for HLA class II
expression on T cells.
The fraction of NK cells was markedly elevated in three
of the totally four analysed influenza patients yielding a
mean % value more than double of that seen in any indi-
vidual among the normal controls or the other patient
groups; however, with no statistical significance due to a
low value in the fourth patient presenting with a history
of more than one week of subacute disease (Figure 3A)
[11]. Interestingly, there was a statistically significant
reduction of % NK cells in the Gr- group (p < 0.01) (Fig-
ure 3A). There were no significant differences in the frac-
tion of B lymphocytes (Figure 3B). The cellular subtypes
B1 among the B cells, and of gamma/delta T-cell recep-
tor-positive T cells (herein defined by a CD3+ CD4-
CD8- phenotype, shown by us previously to contain
mostly gamma/delta T-cell receptor-positive T cells,
results not shown), both being associated with mucosal
immunity, did not show any signs to be a marker for any
of the studied patient groups (Figure 3C-D). The low rela-
tive frequencies of B cell types and NK cells for EBV
patients may be attributed to the marked expansion of
CD8+ T cells leading to lymphocytosis, as described
above for Figure 1A.
Monocytes were investigated for several aspects; by a
routine automated count of total monocytes (Table 1), by
flow cytometry determination of the monocyte CD3-
CD14+ CD16+ subtype (as % of all cells with light scatter
properties typical for monocytes), and by CD40 intensity
on the surface of the major CD3- CD14+ CD16- mono-
cyte subtype, and finally by ELISA assay of plasma
sTNFRI and sTNFRII [5,12,13]. Total monocyte count
was elevated in most of the patients, as expected from
their inflammatory clinical presentation; however, with a
large inter-individual variation illustrated by the tubercu-
losis group with only two among the five studied individ-
uals showing an increased total monocyte count (Table
1). Similarly, although plasma-CRP was elevated in most
patients, there were cases presenting with values as low as
2.5 in the EBV group and < 2 mg/l among the tuberculosis
and neuroborreliosis groups, providing no clear evidence
of on-going infection (Table 1). In the control group (N)
5% of all monocytes were identified as belonging to the
CD16+ subtype, whereas all the patient groups showed a
higher frequency; for the Gr-, EBV and Inf groups at >
25% with statistical significance, and also among the Tb
patients at the lower level of 13.7% but also with high sig-
nificance (p  < 0.01) (Figure 4A). Expression of CD40
(with CD40L = CD154 as its functional ligand on T cells)
was evident on all CD14+ CD16- monocytes, but with a
clearly increased density among all the studied patient
groups (Figure 4B). The strongest expression was seen in
the Gr- and EBV patients (p < 0.01), and a 2-3 fold eleva-
tion was evident in the Inf (p < 0.05), Tb (p < 0.02) and Bo
(p  < 0.05) groups. The MCT patients also showed an
intermediate (4-fold) increase in CD40 expression. The
CD16+ monocyte subset similarly showed an increase in
CD40, but with a larger inter-individual variation (results
not shown). Flow cytometry dot-plot raw data from rep-
resentative cases are shown in Figure 2G-I, to illustrate
the strategy for determination of the intensity of CD40 on
the monocyte surface. Plasma levels of soluble TNF alpha
receptors were elevated in most patients, but with a wide
variation, and with clear statistical significance only for
the Gr- patients (Table 1).
Discussion
The present study was set up in order to determine
whether multi-colour flow cytometry, now performed in
many clinical diagnostic laboratories, can help us in the
clinical assessment of patients with uncharacteristic
inflammatory symptoms. Can it assist us by identifying
lymphocyte and monocyte immunophenotypes suggest-
ing an autoimmune disorder, or an on-going bacterial or
viral infection?
An informative pattern was indeed obtained, by com-
bining some of the analysed markers: the level of CD40
on monocytes with the fractions of HLA-DR-expressing
CD4+ T cells and CD8+ T cells. For example, the
obtained evidence suggests that an intermediate CD40
elevation in monocytes plus a large fraction of activated
cells among the CD4+ T helper cells is indicative of sub-
acute bacterial tuberculosis and borrelia infections. A
similar pattern was seen among the mixed connective tis-
sue disorder patients, however, with same levels of activa-
tion in the CD4+ T cells as in the CD8+ T cells. Statistical
significance was reached for only some of the observed
differences, and future studies on larger number of
patients are needed in order to assess the full discrimina-
tory power of these assays. Analysis of antinuclear anti-
bodies and rheumatoid factor may therefore help toJanols et al. BMC Infectious Diseases 2010, 10:205
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discriminate between infection and mixed connective tis-
sue disorder in patients presenting with this type of pat-
tern. Also NK cells provide valuable information since a
marked increase was evident only in the influenza group
(but not in the case of EBV, despite a clear virus pattern as
determined by monocyte CD40 plus CD8+ T cells). We
believe that activation markers (such as the informative
CD40 and HLA-DR) for a principal reason are able to
provide more reliable and easy-to-evaluate information
than values expressed as percentage of all lymphocytes or
leukocytes. This can be exemplified by the very strong
increase in the number of CD8+ T cells in the EBV
patients, causing the fractions of all other lymphocytes to
be correspondingly decreased; thus, the low percentages
of NK cells and of mucosal T and B cells cannot be
assumed to reflect any influence by EBV on these cell
types. In this context, it is interesting to turn the attention
to the enterobacteriacae Gr- group: here the low values of
NK cell fraction and T cell activation (both for CD4+ T
and CD8+ T) cannot be considered to be secondary to
lymphocytosis or any other of the assayed parameters.
Instead, it suggests a direct effect on these cell types and,
consequently, that less-needed immune functions can
become down-regulated, in analogy with a study finding
bacterial superinfections and a decreased granulocyte
reactivity during a viral interferon-gamma response [14].
Figure 2 Flow cytometry method for quantitation of T cell and monocyte activation status. Representative dot plots from analysis of patient 
samples are shown. CD4+ T cells and CD8+ T cells gated on CD3+ CD4+ (A,C,E) and CD3+ CD8+ (B,D,F) lymphocytes from (A-B), a healthy control; (C-
D), tuberculosis; (E-F), influenza; the inserted percentages indicate the fraction of HLA-DR+ cells. Monocyte plots gated on CD3- CD14+ monocytes 
from (G), a healthy control; (H), tuberculosis; (I), influenza; mfi = mean fluorescence intensity.
Healthy control           Tuberculosis patient       Influenza patient
       HLA-DR                                                                                                             
            CD40 
2.2%     A
C
D
8
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5.5%    C 3.0%     E
2.6%    B 14.3%     F
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Our preliminary results from patients with uncharac-
teristic inflammatory disorders (n = 11, 8 females and 3
males), as defined by for example long-standing fatigue or
pain, and no more specific diagnosis, show an elevated
monocyte CD40 expression in most, but not all, cases
(mean value 6 times higher than normal controls); an
increased fraction of the CD14+ CD16+ monocyte subset
(15% of all monocytes); and a most diverse T lymphocyte
pattern. These patients have as yet not been followed-up
with regard to additional tests or treatments.
Figure 3 NK cells, B cells and mucosal subtypes of B and T cells. The results show the fraction among all blood lymphocytes of (A), NK cells; (B), B 
cells; (C), CD5+ B1 subtype of B cells; (D), gamma/delta TCR+ subtype of T cells as determined by a CD3+ CD4- CD8- phenotype. The dashed lines 
indicate the level of the normal controls. ** p < 0.01.
4.0
5.0
3.0
2.0
1.0
D
2.0
3.0
1.0
4.0
C
5
10
20
25 A
15
30
**
Gr- EBV Inf     Tb       Bo     MCT     N
   10    
20
5
B
**
Gr- EBV  Inf     Tb      Bo     MCT    N
Gr- EBV  Inf    Tb    Bo   MCT N         Gr- EBV Inf  Tb      Bo  MCT N
B
 
c
e
l
l
s
(
%
 
o
f
 
 
l
y
m
p
h
o
c
y
t
e
s
)
C
D
 
1
9
+
5
+
 
B
1
 
c
e
l
l
s
 
 
(
%
 
 
o
f
 
l
y
m
p
h
o
c
y
t
e
s
)
C
D
3
+
4
-
8
-
T
 
c
e
l
l
s
 
 
(
%
 
 
o
f
 
 
l
y
m
p
h
o
c
y
t
e
s
)
N
K
 
c
e
l
l
s
 
(
%
o
f
 
l
y
m
p
h
o
c
y
t
e
s
)Janols et al. BMC Infectious Diseases 2010, 10:205
http://www.biomedcentral.com/1471-2334/10/205
Page 7 of 9
Our study also shows that a number of potentially
informative markers do not provide any discrimination.
The fractions of B cells, CD5+ B cells and gamma/delta
TCR+ CD3 + CD4- CD8- T cells (Figure 2B-D) did not
show values different from the normal control persons;
the latter two parameters are usually considered to play a
role for mucosal immunity [15]. The CD14 and CD16
double-positive monocyte subpopulation showed much
the same result as CD40 expression on classical CD14 +
16- monocytes, but with a large inter-individual variation
limiting their value for clinical use. We assayed some
additional cell types which did not provide any discrimi-
nation, without presenting the results; CD34 + CD45 low
hematopoietic progenitor cells, present in peripheral
blood at a fraction of 0.1% of all leukocytes and reported
to become dramatically increased during an infection
[16]; plasmacytoid dendritic cells [13], reported to
increase during viral infections and in mixed connective
tissue disorders; CD27 and CD45R0 memory and effector
subtypes of CD8 + T cells, reported to be affected during
persistent virus infections [17]. Likewise, CD69, CD71, as
markers for T cell activation, as well as CD152 (CTLA-4)
were found to be expressed only at low levels, and with no
difference between patients and controls. No additional
monocyte markers were investigated. It is known that
activation antigen expression by T cells in vivo is deter-
mined by many factors such as body site, length of time of
stimulation, and type of antigen [18]. We considered
HLA-DR to be a suitable activation marker for the pres-
ent study, not only because of its fluorescence intensity,
but also with regard to its in vivo expression (whereas e.g.
CD25, i.e. the IL2R, is more easily detected in vitro), and
to its kinetics, peaking relatively late (whereas e.g. CD69
appears already 2 h after stimulation, to disappear at day
5).
We also assayed CD4 + T regulatory cells, but were not
able to obtain high enough mean fluorescent intensities
for CD25 and FoxP3 for a meaningful evaluation. Inter-
Figure 4 Monocytes: (A), fraction among all monocytes of the CD16+ subtype; and (B), activation status as determined by CD40 expression. 
The dashed lines indicate the level of the normal controls. *p < 0.02 or 0.05, ** p < 0.01.
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estingly, we could not document any increase in CD154
(the CD40 ligand) on T cells, and therefore decided not to
include CD154 in our standard panel. This finding may
seem unexpected, since this surface marker on CD4 + T
cells is known to interact with CD40 on antigen-present-
ing cells, found by us to become strongly up-regulated on
monocytes [19]. Nevertheless, it is well-known that func-
tional ligation by macrophages/monocytes with T cell
CD40 ligand is important for their CD40 expression and
effector functions such as TNF alpha and nitric oxide
production [20]. Moreover, genetic studies have recently
documented an important association between rheuma-
toid arthritis and CD40 variants, supporting the rele-
vance of CD40 for inflammatory disease development
[21]. Analysis of sTNFRs was also less informative due to
a large variation, which may indicate that cellular activa-
tion markers in general have higher discrimination power
than soluble cytokine and chemokine analytes, however,
this remains for future studies to determine.
We have some evidence that the immunophenotype
patterns found by us really provide superior information
as compared with commonly used and more simple-to-
assay parameters. In clinical practice a CRP value of 100
mg/l is often used as a crude cut-off, with a higher figure
suggesting a bacterial rather than a viral origin of an
infection. However, plasma-CRP was > 100 mg/L in some
of the influenza patients, and < 100 mg/l for 14 of the 15
subacute bacterial tuberculosis and borreliosis patients,
thus showing no reliable discrimination between viruses
and bacteria. In addition, the range of CRP was wide
within several patient groups, including some EBV, tuber-
culosis and neuroborreliosis patients presenting with a
CRP of < 2 mg/l or 2 mg/l and thus giving no obvious
indication of on-going infection. Other serum markers
reported to be of use for rapid diagnosis of an infection
were not assayed, such as procalcitonin in severe bacte-
rial infections, neopterin and levels of cytokines or solu-
ble cytokine receptors. The data obtained in the present
study cannot exclude the possibility that the phase of the
disease, i.e. acute versus chronic, rather than the type of
disease, is the main determinant of the observed patterns.
Future studies on a larger patient material may be helpful
to clarify this issue. Interestingly, there was a normal
monocyte count in all the EBV patients indicating that
there is no simple relation between immune parameters
assessed in peripheral blood and disease stage. However,
there was a more than 3-fold increase in monocyte acti-
vation in all of the EBV patients, as compared with the
highest CD40 level encountered among all of the control
individuals. Likewise, although the tuberculosis group
had an elevated mean number of monocytes, there was a
large variation with only 2 of these 8 patients falling out-
side the normal range of monocyte count; in contrast the
monocyte activation was increased in each patient.
Conclusions
Immunophenotyping of lymphocytes and monocytes
including quantities of the fractions of HLA-DR express-
ing T cells and the level of CD40 expression on mono-
cytes can differentiate between acute bacterial and viral
infections. Novel findings are presented, suggesting that
it also provides some indication of a subacute bacterial
infection, such as neuroborreliosis or tuberculosis; as well
as of a mixed connective tissue disorder, respectively. The
employed flow cytometric method is suitable for clinical
diagnostic laboratories, and promises to be a source of
valuable clinical information for patients with uncharac-
teristic inflammatory symptoms, guiding further diag-
nostic testing and providing a rationale for ex juvantibus
therapy. Further studies involving a larger number of
patients are warranted, in order to determine the full
clinical discriminatory power of this diagnostic tool.
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